Technical Analysis for ENDP - Endo Health Solutions Inc.

Grade Last Price % Change Price Change
D 6.26 3.47% 0.21
ENDP closed up 3.47 percent on Friday, April 16, 2021, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical ENDP trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish 3.47%
Wide Bands Range Expansion 3.47%
Oversold Stochastic Weakness 3.47%
Stochastic Buy Signal Bullish -0.16%
Wide Bands Range Expansion -0.16%
Oversold Stochastic Weakness -0.16%
Narrow Range Bar Range Contraction 2.45%
NR7 Range Contraction 2.45%
Older End-of-Day Signals for ENDP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% about 23 hours ago
Up 2% about 24 hours ago
60 Minute Opening Range Breakout 1 day ago
Up 1% 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Endo Health Solutions Inc. Description

Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. The company's Endo Pharmaceuticals segment offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel for pain, urology, endocrinology, and oncology. Its Qualitest segment provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. The company's AMS segment offers various technology solutions comprising AMS 700 MS series, AMS 800 artificial urinary sphincter, GreenLight XPS laser system, Elevate transvaginal pelvic floor repair system, and Monarc subfascial hammock products in the areas of men's and women's health, and BPH therapy. Its HealthTronics segment provides urological services, such as lithotripsy, prostate treatment, anatomical pathology, and electronic medical record services to urologists, hospitals, surgery centers, and clinics; and manufactures, sells, and maintains medical devices for tissue and tumor ablation. The company's products under development primarily include Aveed, an injectable testosterone preparation to treat male hypogonadism; BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain; ODM-201, an androgen receptor antagonist in Phase II clinical testing to treat castrate resistant prostate cancer; and EN3342, a polyurethane implant in Phase I/II trials for the maintenance treatment of schizophrenia in adults. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. The company was formerly known as Endo Pharmaceuticals Holdings Inc. and changed its name to Endo Health Solutions Inc. in May 2012. Endo Health Solutions Inc. was founded in 1997 and is headquartered in Malvern, Pennsylvania.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Laser Pain Clinics Surgery Chemical Compounds Organic Compounds Technology Solutions Prostate Cancer Hypertension Tumor Urology Schizophrenia Pain Management Chronic Pain Nervous System Disorders Central Nervous System Disorders Ablation Healthcare Solution Healthcare Solutions Polyurethane Anatomical Pathology Opioids Pathology Endocrinology Health Solutions Laser System Vagina Resistant Prostate Cancer Testosterone Treatment Of Schizophrenia Prescription Product Prescription Products Pharmaceuticals Segment Severe Chronic Pain Androgen Receptor Buprenorphine Lithotripsy Moderate To Severe Chronic Pain Diclofenac Generic Products Hypogonadism Immunosuppression

Is ENDP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.89
52 Week Low 2.71
Average Volume 3,340,753
200-Day Moving Average 5.53
50-Day Moving Average 8.04
20-Day Moving Average 7.10
10-Day Moving Average 6.47
Average True Range 0.47
ADX 26.4
+DI 13.36
-DI 28.83
Chandelier Exit (Long, 3 ATRs ) 7.16
Chandelier Exit (Short, 3 ATRs ) 7.37
Upper Bollinger Band 8.67
Lower Bollinger Band 5.54
Percent B (%b) 0.23
BandWidth 44.11
MACD Line -0.52
MACD Signal Line -0.44
MACD Histogram -0.0827
Fundamentals Value
Market Cap 1.44 Billion
Num Shares 230 Million
EPS -2.62
Price-to-Earnings (P/E) Ratio -2.39
Price-to-Sales 0.44
Price-to-Book 0.00
PEG Ratio -0.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.76
Resistance 3 (R3) 6.72 6.50 6.68
Resistance 2 (R2) 6.50 6.37 6.52 6.65
Resistance 1 (R1) 6.38 6.29 6.44 6.43 6.62
Pivot Point 6.17 6.17 6.20 6.19 6.17
Support 1 (S1) 6.05 6.04 6.11 6.09 5.90
Support 2 (S2) 5.83 5.96 5.85 5.87
Support 3 (S3) 5.71 5.83 5.84
Support 4 (S4) 5.76